Schering-Plough, Merck’s Vytorin misses study goal / no better than placebo and startled to see about 50 percent more new cancer cases and cancer deaths in patients
Public release date: 21-Jul-2008 In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of…
You must be logged in to post a comment.